Usefulness and robustness of Immunoscore for personalized management of cancer patients.

Saved in:
Bibliographic Details
Title: Usefulness and robustness of Immunoscore for personalized management of cancer patients.
Authors: Marliot F; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France.; Equipe Labellisée Ligue Contre le Cancer, Paris, France.; Centre de Recherche DES Cordeliers, Sorbonne Université, Université de Paris, Paris, France.; Immunomonitoring Platform, Laboratory of Immunology, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, Paris, France., Pagès F; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France.; Equipe Labellisée Ligue Contre le Cancer, Paris, France.; Centre de Recherche DES Cordeliers, Sorbonne Université, Université de Paris, Paris, France.; Immunomonitoring Platform, Laboratory of Immunology, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, Paris, France., Galon J; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France.; Equipe Labellisée Ligue Contre le Cancer, Paris, France.; Centre de Recherche DES Cordeliers, Sorbonne Université, Université de Paris, Paris, France.
Source: Oncoimmunology [Oncoimmunology] 2020 Oct 13; Vol. 9 (1), pp. 1832324. Date of Electronic Publication: 2020 Oct 13.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Electronic Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology
Database: MEDLINE Ultimate
Description
ISSN:2162-4011
DOI:10.1080/2162402X.2020.1832324